Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Ninlaro Misses Primary Goal in Front-Line Myeloma Study
March 12, 2020
- Nipro Confirms Coronavirus Infection Case at Niigata Branch
March 12, 2020
- Shionogi Wins Osaka Tax Suit over ViiV Deal
March 12, 2020
- Santen Calls Off Development of wAMD Treatment after PIIa Fails
March 12, 2020
- Kowa’s Glaucoma Med Glanatec Approved in Singapore
March 12, 2020
- Drug Makers Calling Off Welcoming Ceremonies for New Hires over Coronavirus
March 11, 2020
- Relugolix Combo Tablet Filed in EU for Uterine Fibroids
March 11, 2020
- Janssen Files for Darzalex in Japan for Combo Therapy with Carfilzomib, Dexamethasone
March 11, 2020
- Medipal Forms Capital and Business Alliance with Cardiac Regenerative Medicine Startup
March 11, 2020
- Pfizer Most Affected by G1 Rule, 8 Off-Patent APIs Go into This Category: Jiho Survey
March 10, 2020
- Japan’s 2020 Price Revision Hits Major Drugs with Double-Digit Slashes: Top 5 Product Survey
March 10, 2020
- Takeda Continued Takecab Push for Hospital Doctors in January: Impact Track
March 10, 2020
- Biogen’s Coronavirus Woes Grow, Japan Unit Says Its Staffers Attended Boston Confab Too
March 10, 2020
- Shionogi Confirms Novel Coronavirus Infection at Its Group Company
March 10, 2020
- Aducanumab “on Track” for FDA Filing: Eisai CEO
March 9, 2020
- FTC Hits Torii with Cease, Desist, and Surcharge Payment Order over Price-Fixing for Calvan
March 9, 2020
- Japan’s Big 3 Generic Makers See 12.2% Price Cut vs. FY2018: Jiho Poll
March 9, 2020
- FDA Accepts Vibegron for Review; Target Date Set for Dec. 26
March 9, 2020
- Shionogi Boosts Stake in Tetra under Alzheimer's Deal; Buyout on the Cards
March 9, 2020
- Japan Ethical Drug Sales Down 1.2% in January: Crecon
March 9, 2020
